- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
München, Ludwig-Maximilians-Universität, Dissertation, 2018
- Klassifikation
-
Medizin, Gesundheit
- Schlagwort
-
Stability
Antibody-drug conjugates
Light--Scattering
- Ereignis
-
Veröffentlichung
- (wo)
-
München
- (wer)
-
Universitätsbibliothek der Ludwig-Maximilians-Universität
- (wann)
-
2018
- Urheber
-
Dürr, Corinna
- Beteiligte Personen und Organisationen
-
Frieß, Wolfgang
- URN
-
urn:nbn:de:bvb:19-223874
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:47 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dürr, Corinna
- Frieß, Wolfgang
- Universitätsbibliothek der Ludwig-Maximilians-Universität
Entstanden
- 2018
Ähnliche Objekte (12)
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Antibody–drug conjugates as an emerging therapy in oncodermatology
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Antibody stability maturation by in vitro evolution
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Antibody drugs at the liquid-air interface: physicochemical characteristics, aggregation & the impact of formulation
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Antibody–drug conjugates as an emerging therapy in oncodermatology
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Antibody stability maturation by in vitro evolution
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases
Antibody drugs at the liquid-air interface: physicochemical characteristics, aggregation & the impact of formulation
Impact of Different Conjugation Approaches on Physicochemical Stability of Antibody-Drug Conjugates
Antibody–drug conjugates as an emerging therapy in oncodermatology
Multivalent Functionalized Dextran-Antibody Conjugates for Efficient Tumor Cell Killing
Covalent gold nanoparticle-antibody conjugates for sensivity improvement in LFIA
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Site‐Specific Antibody Fragment Conjugates for Reversible Staining in Fluorescence Microscopy
Design and generation of antibody-drug conjugates using non-canonical amino acids
Refinement of antibody drug conjugates by enhancing the genetic code expansion technology
Ethynylphosphonamidates for the Rapid and Cysteine-Selective Generation of Efficacious Antibody–Drug Conjugates
Antibody stability maturation by in vitro evolution
Improved Drug Delivery of next-generation Antibody-Drug Conjugates by utilizing tumor-associated proteases